Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Germline ApoE variants affect melanoma trajectory

May 26, 2020

New SSAO inhibitors identified at Boehringer Ingelheim

May 26, 2020

Karus Therapeutics initiates phase II study of KA-2507 in biliary tract cancer

May 26, 2020

FDA approves Alunbrig for ALK-positive metastatic NSCLC

May 25, 2020

Beijing Tide Pharmaceutical patents ROCK2 inhibitors

May 25, 2020

FDA accepts IND application for phase I/II study of NT-219 in advanced cancer

May 25, 2020

Phase III trial of entinostat in HR-positive, HER-negative breast cancer misses primary endpoint

May 22, 2020

New RET inhibitors presented by Medshine Discovery

May 22, 2020

Novel mouse model for small cell carcinoma of bladder

May 21, 2020

FDA approves Lynparza for HRR gene-mutated castration-resistant prostate cancer

May 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...